Stockscreener 앱 받기
3.3375
0.89%
-0.0225
전일 마감가:
$3.36
열려 있는:
$3.33
하루 거래량:
106.97K
Relative Volume:
1.55
시가총액:
$1.74M
수익:
-
순이익/손실:
$-8.82M
주가수익비율:
-0.00483
EPS:
-691.4213
순현금흐름:
$-8.08M
1주 성능:
+5.38%
1개월 성능:
-22.56%
6개월 성능:
-77.24%
1년 성능:
-99.24%
1일 변동 폭
$3.2641
$3.65
1주일 범위
$3.02
$5.58
52주 변동 폭
$3.02
$664.82
Endra Life Sciences Inc Stock (NDRA) Company Profile
명칭
Endra Life Sciences Inc
전화
734-335-0468
주소
3600 GREEN COURT, ANN ARBOR, MI
NDRA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
3.3606 | 1.74M | 0 | -8.82M | -8.08M | -691.42 |
|
TMO
Thermo Fisher Scientific Inc
|
434.46 | 169.62B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
195.24 | 138.06B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
418.00 | 32.79B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
101.80 | 29.99B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
141.93 | 26.61B | 15.41B | 1.37B | 2.11B | 7.50 |
Endra Life Sciences Inc 주식(NDRA)의 최신 뉴스
NDRA stock touches 52-week low at $3.05 amid sharp annual decline By Investing.com - Investing.com South Africa
NDRA stock touches 52-week low at $3.05 amid sharp annual decline - Investing.com India
Reshape Lifesciences Stock Price, Quotes and Forecasts | NASDAQ:RSLS - Benzinga
ENDRA Life Sciences Stock Gains Market Momentum - Stocks Telegraph
ENDRA Life Sciences Advances TAEUS Liver Device Strategy - TipRanks
ENDRA Life Sciences pivots to metabolic health market - Investing.com
ENDRA Life Sciences Inc. (NDRA) reports earnings - Quartz
ENDRA Life Sciences Inc. SEC 10-K Report - TradingView
How ENDRA's AI-Powered Device Could Transform GLP-1 Weight Loss Treatment Monitoring - Stock Titan
ENDRA Slashes Monthly Expenses 37% as TAEUS Liver Device Advances - Stock Titan
ENDRA Life Sciences Inc expected to post a loss of $4.10 a shareEarnings Preview - TradingView
ENDRA Life Sciences (NDRA) Projected to Post Earnings on Thursday - Defense World
ENDRA Life Sciences Strengthens TAEUS® System Intellectual Property with Issuance of 24th U.S. Patent - Business Wire
ENDRA Life Sciences stock hits 52-week low at $3.89 amid steep decline - Investing.com Canada
ENDRA Life Sciences Announces New Clinical Study Partnership with Inselspital University Hospital in Bern, Switzerland - ACCESS Newswire
Critical Contrast: ENDRA Life Sciences (NASDAQ:NDRA) vs. Gadsden Properties (OTCMKTS:GADS) - Defense World
ENDRA Life Sciences to Participate at Upcoming Investor Conferences - ACCESS Newswire
ENDRA Life Sciences Strengthens Global Intellectual Property Protection with Issuance of Two European Patents Related to its TAEUS Probe - ACCESS Newswire
ENDRA Life Sciences Issued Chinese Patent for Its TAEUS(R) Platform Technology to Calculate Fat Concentration in Tissue - ACCESS Newswire
Where are the Opportunities in (NDRA) - Stock Traders Daily
What Makes ENDRA Life Sciences (NDRA) a New Strong Buy Stock - MSN
Financial Contrast: NeurAxis (NASDAQ:NRXS) versus ENDRA Life Sciences (NASDAQ:NDRA) - Defense World
(NDRA) On The My Stocks Page - Stock Traders Daily
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.36% - MSN
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.14% - MSN
(NDRA) Trading Signals - Stock Traders Daily
Study Highlighting ENDRA Life Sciences TAEUS Technology in Patients with High BMI to be presented at AASLD's The Liver Meeting 2024 - Marketscreener.com
Data I/O And 2 Other Stocks Under $5 Executives Are Buying - MSN
Nexalin Technology (NASDAQ:NXL) and ENDRA Life Sciences (NASDAQ:NDRA) Head-To-Head Survey - Defense World
(NDRA) Technical Data - Stock Traders Daily
ENDRA Life Sciences Inc trading halted, volatility trading pause - TipRanks
ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement - Defense World
ENDRA Life Sciences meets Nasdaq listing standards By Investing.com - Investing.com Australia
ENDRA Life Sciences meets Nasdaq listing standards - Investing.com
Endra Life Sciences regains compliance with Nasdaq - TipRanks
ENDRA Life Sciences Regains Nasdaq Compliance, Clears Path for Strategic Growth | NDRA Stock News - StockTitan
ENDRA Life Sciences Reports Q3 2024 Results and Progress - TipRanks
Post Holdings beats Q4 estimates, issues fiscal 2025 outlook - Investing.com
ENDRA Life Sciences Cuts Operating Costs 52%, Accelerates Clinical Trial Progress | NDRA Stock News - StockTitan
ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update - Business Wire
NDRA stock touches 52-week low at $5.23 amid sharp annual decline - Investing.com
500: Something went wrong - Investing.com India
ENDRA's TAEUS Breakthrough: Liver Fat Detection in High-BMI Patients Validated for AASLD 2024 | NDRA Stock News - StockTitan
U.S. Stock market: Wolfspeed, ENDRA Life Sciences, and Clear Secure see significant declines with Wolfspeed down 32.10% - Business Upturn
U.S. Stock market: Cardlytics(- 30%0, CommScope (-26%) and Wolfspeed (-5%) among top losers as the market opens - Business Upturn
Turkey hopes for lower US tariffs under Trump, lira rallies - Investing.com
ENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European Patent - The Bakersfield Californian
ENDRA Life Sciences Secures 17th EU Patent for Revolutionary Surgical Technology | NDRA Stock News - StockTitan
ENDRA Life Sciences announces reverse stock split - Investing.com India
ENDRA Life Sciences announces reverse stock split By Investing.com - Investing.com UK
Endra Life Sciences Inc (NDRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.80%
1.42%
자본화:
|
볼륨(24시간):